The British Skin Foundation is seen as a vital source of funding for skin cancer research. Its robust grant awarding process ensures only the highest level of research is funded*, and it is well respected within the scientific community. With the help of some of the UK's leading dermatologists and skin cancer experts, each application is carefully reviewed by its 22 person strong committee, and the quality of each research project and the ultimate benefit of it to the patient is carefully assessed.
In 2013, the charity received close to 100 applications to fund research totalling over £5 million. It was only able to fund 17 of these, even though many more were of a quality deemed to be worth our support. With your help, It Takes 7 will allow the British Skin Foundation to fund many more research projects into skin cancer than it is currently able to. Together, this will help further our understanding of the complex disease, and take us a one step closer to finding a cure.
* The BSF is a member of the Association of Medical Research Charities (AMRC) and the charity has been reviewed by the organisation as having a highly robust grant giving process.
Dr Penny Lovat
Grants advisory committee member
Dr Andrew Chantry, School of Biological Sciences, University of East Anglia
Research title: Developing a new therapeutic approach to target melanoma growth and metastasis, and, Novel therapeutics targeting the WWP2 Ubiquitin Ligase oncogene in malignant melanoma
Dr Robert Ellis, Lovat Research group, Dermatological Sciences Laboratories, Newcastle University
Research title: Validation of WIPI-1 as a biomarker of autophagy and therapeutic target in melanoma
Professor D Gareth Evans, Consultant in Clinical Genetics at the Department of Genetic Medicine, St Mary's Hospital
Research title: A genetic investigation of basal cell carcinoma
Professor David A Greenhalgh, Analysis of p53, p21 and PTEN mediated inhibition of malignant conversation in transgenic mouse skin carcinogenesis
Research title: Glasgow University
Dr Andy South, School of Medicine, University of Dundee
Research title: Targeting C20orf20 for cutaneous squamous cell carcinoma therapy
Dr Girish Patel, European Cancer Stem Cell Research Institute, Cardiff University
Research title: Targeting CD200 signalling to overcome human basal cell carcinoma immune-evasion